Table-1.
Melanoma | ||
Lin− HLA-DR− CD33+ | [19] | |
CD15+ IL4Rα+ | [21] | |
CD14+ IL4Rα+ | ||
[135] | ||
CD14+ HLA-DR−/low | [136] | |
[137] | ||
CD14+ HLA-DR−/low Stathigh CD80+ | [136] | |
CD83+ DC-Sign+ | ||
CD14+ HLA-DR−/low | [135] | |
CD11b+ HLA-DR− Lin− | [138] | |
CD14+ HLA-DR− Lin− | ||
CD33+ HLA-DR− Lin− | ||
CD15+ HLA-DR− Lin− | ||
Breast Cancer | ||
Lin− HLA-DR− | [19] | |
Lin−/low HLA-DR− CD33+ CD11b+ | [137] | |
CD15+ granulocytes | [139] | |
CD15+ FSClow SSChigh | ||
Central Nervous System cancers |
||
Neuroblastoma | CD11b+ CD33+ HLA-DR− | [140] |
Glioblastoma | CD14+ CD33+ HLA-DR−/low | [141] |
CD15+ CD33+ HLA-DR− | ||
Head and Neck Squamous Cell |
Lin− HLA-DR− | [19] |
CD11b+ CD14− CD33+ | [142] | |
CD14+ | [125] | |
SSChigh CD66b+ | [143] | |
Lung | ||
NSCLC | CD11b+ CD14− CD15+ CD33+ | [144] |
Lung Cancer | Lin− HLA-DR− | [19] |
CD11b+ CD33+ | [145] | |
SSChigh CD66b+ | [143] | |
Gastrointestinal Cancers |
||
Hepatocellular carcinoma | CD14+ HLA-DR−/low | [146] |
Gastrointestinal | CD15+ CD14+ CD11b+ CD33+ | [87] |
Cancer | HLA-DR− | |
Colon | CD15+ IL4Rα+ | [21] |
CD14+ IL4Rα+ | ||
CD15+ granulocytes | [139] | |
CD15+ FSClow SSChigh | ||
CD14+ HLA-DR−/low S100A9+ | [147] | |
Pancreas | CD15+ granulocytes | [139] |
CD45+ Lin− CD33+ CD11b+ CD15+ | [148] | |
Renal Cancers | ||
CD14+ IL-4Rα+ | [149] | |
CD15+ IL-4Rα+ | ||
CD14+ HLA-DR−/low | ||
CD11b+ CD14− CD15+ | ||
CD15+ FSClow SSChigh | ||
Lin− HLA-DR− CD33+ | ||
Lin− HLA-DR− CD33+ | [150] | |
[151] | ||
CD33+ HLA-DR− | [152] | |
CD15+ CD14− | ||
[153] | ||
CD11b+ CD14− CD15+ | [154] | |
[155] | ||
CD14+ HLA-DR−/low | [156] | |
CD14+ HLA-DR−/low | [155] | |
Genitourinary Malignancies |
||
Prostate | CD14+ HLA-DR−/low | [20] |
Bladder & Uretheral | SSChigh CD66b+ | [143] |
Ovarian | CD11b+ CD14+ CD15+ CD33+ | [123] |
HLA-DRlow CD33+ CD80− CD83− |
Abbreviations: SSC: side scatter FSC: forward scatter Lin: lineage DC-Sign: Ctype lectin highly expressed on dendritic cell